Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
NINGBO INNO PHARMCHEM CO.,LTD. is at the forefront of supplying advanced pharmaceutical ingredients that drive therapeutic progress. Aprepitant (CAS 170729-80-3) exemplifies this, representing a significant advancement in antiemetic therapy through its cutting-edge NK1 receptor antagonist technology.
The development of Aprepitant marked a paradigm shift in managing nausea and vomiting, particularly those induced by highly emetogenic chemotherapy. Unlike older antiemetics that primarily targeted serotonin or dopamine receptors, Aprepitant directly addresses the role of Substance P and its interaction with the NK1 receptor in the brain's vomiting center. This targeted approach, leveraging the understanding of the Aprepitant mechanism of action, provides superior control over both acute and delayed emesis.
The pharmaceutical applications of Aprepitant are far-reaching. Its efficacy has been established not only in oncology but also in preventing postoperative nausea and vomiting (PONV), improving patient outcomes and recovery times across various surgical procedures. The ability to cross the blood-brain barrier and occupy central NK1 receptors is crucial to its therapeutic effect, differentiating it from peripherally acting antiemetics.
NINGBO INNO PHARMCHEM CO.,LTD. plays a vital role in making this advanced therapy accessible. By ensuring the high purity and quality of our Aprepitant, we support the pharmaceutical industry in formulating effective antiemetic medications. Our expertise in the Aprepitant synthesis pathway ensures a consistent and reliable supply of this critical API.
The continued innovation in NK1 receptor antagonist technology, with Aprepitant leading the way, promises further improvements in patient care. NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to supporting this ongoing evolution by providing the foundational pharmaceutical chemicals needed for research and manufacturing. Partner with us to access quality Aprepitant and contribute to the advancement of antiemetic therapies.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
